Click Here to return To Results

 

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009 See this aricle in Pubmed Article Abstract Influence of anti-TNF-� treatment continuation on the long-term course of neuropathy is variable, suggesting that anti-TNF-� treatment withdrawal is not always for neuropathy control.

Related Tags

(click to filter results - removes previous filter) adalimumab adverse drug reaction complications etanercept gammaglobulin therapy,intravenous immunosuppressive agents infliximab monoclonal antibodies nerve biopsy neuropathy neuropathy,iatrogenic neuropathy,medication induced polyneuropathy,chronic inflammatory demyelinating prognosis regional enteritis treatment of neurologic disorder tumor necrosis factor inhibitor

Click Here to return To Results